Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
CVS Health, owner of MinuteClinics, is trying to buy Aetna. Photo: Dina Rudick/The Boston Globe via Getty Images
"Attractive" profit margins and an aging population are the main reasons for the rush of health care mergers and acquisitions, according to a survey of health care and private equity dealmakers conducted by consulting firm West Monroe Partners.
Reality check: Even though health care players say "value-based care" drives their decision-making, the survey is a candid reminder a lot of the industry is driven by making money rather than improving care.
Driving the news: The West Monroe survey of 100 executives found three predominant factors that will make health care companies appealing takeover targets over the next 1-3 years:
- Attractive profit margins
- Aging population
- Overall growth in demand for care
Between the lines: There's no talk here about "patient-centered coordination" or "controlling spending growth." The responses suggest that dealmakers, especially those in private equity, know they can extract profit from companies that get a lot of revenue from government programs.
But not too much: Many companies and buyout firms have balked at closing deals "if a final analysis shows a large portion of government reimbursement" in a target company's finances. Almost three-fourths of respondents said they have walked away from a deal, due in part to the lower rates paid by Medicare and Medicaid.
- A shortage of quality companies, crazy-high valuations and too much debt also have scared off some parties from acquiring health care companies.